AU Patent

AU2017361078B2 — Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use

Assigned to Temple Univ School of Medicine · Expires 2022-01-06 · 4y expired

What this patent protects

Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

USPTO Abstract

Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017361078B2
Jurisdiction
AU
Classification
—
Expires
2022-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Temple Univ School of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.